The Effect of BTS Induced Inactivity on a Zebrafish Model of Duchenne Muscular Dystrophy by Driscoll, Sean
The University of Maine 
DigitalCommons@UMaine 
Electronic Theses and Dissertations Fogler Library 
Spring 5-7-2021 
The Effect of BTS Induced Inactivity on a Zebrafish Model of 
Duchenne Muscular Dystrophy 
Sean Driscoll 
University of Maine, sean.driscoll@maine.edu 
Follow this and additional works at: https://digitalcommons.library.umaine.edu/etd 
 Part of the Zoology Commons 
Recommended Citation 
Driscoll, Sean, "The Effect of BTS Induced Inactivity on a Zebrafish Model of Duchenne Muscular 
Dystrophy" (2021). Electronic Theses and Dissertations. 3392. 
https://digitalcommons.library.umaine.edu/etd/3392 
This Open-Access Thesis is brought to you for free and open access by DigitalCommons@UMaine. It has been 
accepted for inclusion in Electronic Theses and Dissertations by an authorized administrator of 
DigitalCommons@UMaine. For more information, please contact um.library.technical.services@maine.edu. 
 
 
THE EFFECT OF BTS INDUCED INACTIVITY ON A ZEBRAFISH MODEL OF 
DUCHENNE MUSCULAR DYSTROPHY 
By 
Sean Driscoll 
B.S. University of Maine, 2019 
 
A THESIS 
Submitted in Partial Fulfilment of the  
Requirements for the Degree of  
Master of Science  
(in Zoology) 
 
The Graduate School  










Advisory Committee  
 Dr. Clarissa Henry, Professor of Biological Sciences, Advisor 
 Dr. Jarod Talbot, Assistant Professor of Developmental Biology  
 Dr. Benjamin King, Assistant Professor of Bioinformatics 
 
 
THE EFFECT OF BTS INDUCED INACTIVITY ON A ZEBRAFISH MODEL OF 
DUCHENNE MUSCULAR DYSTROPHY 
By Sean Driscoll 
Thesis Advisor: Dr. Clarissa Henry 
An Abstract of the Thesis Presented in Partial Fulfillment of the Requirements for the Degree of 




 Duchenne’s Muscular dystrophy (DMD) is a congenital disease of the muscle 
characterized by muscle atrophy, weakness, and a lower quality of life. Often diagnosed in 
children, it affects about 1 in every 5,500-7,700 males. A patient diagnosed with DMD is often 
told to avoid physical activities outside the required amount needed to go on with their day in 
order to preserve the muscle fibers and integrity. Inactivity in a healthy person leads to decreased 
muscle mass and increased weakening of the muscle, so we questioned if the effects may be 
exacerbated in a person diagnosed with DMD having already weakened muscle. In other words, 
‘does inactivity make disease progression worse?’ In this project, we explored the effects of 
inactivity on a zebrafish model of DMD. We used N-Benzyl-p-toluene sulfonamide (BTS), a 
myosin heavy chain inhibitor, to induce total inactivity for 72-hours consecutively at disease 
onset (2 days post fertilization), followed by a 72-hour recovery period out of BTS where normal 
activity is resumed. This setup mimics activity levels that a DMD patient may experience; 
periods of inactivity advised by doctors to preserve muscle fibers followed by use of the muscle 
for an activity such as physical therapy. We then analyzed the effects on muscle structure (via 
birefringence) and function (via swimming distance and velocity), as well as survival. Based on 
 
previous studies done on inactivity and muscle health, we hypothesized that extended inactivity 
would have a deleterious effect on the structure and function of the muscle fibers as well as 
survival. We found that muscle structure and function was not significantly different than control 
disease progression after extended inactivity. Survival was also not significantly different from 
the control. The results of this data show us that while extended inactivity did not worsen disease 
progression as compared to the control, inactivity did not improve muscle structure and function 
or survival. This data is an important step in understanding the effects of inactivity on disease 
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1.1 Skeletal Muscle Structure and Function 
Skeletal muscle is one of the 3 main types of muscle found within the body, the other two 
being smooth and cardiac muscle. Skeletal muscle’s main function is to control the motor 
movements the body uses for any activity such as walking, breathing, running, etc., and its 
structure is uniform across the entire body. However, skeletal muscle has roles in many other 
functions in the human body, including temperature regulation and endocrine function 1. 
Overall, Skeletal muscle is an extremely important organ and proper skeletal muscle health is 
imperative for whole-body health and wellness.  
1.1.1 Skeletal Muscle Structure 
Aside from being one of the most dynamic and plastic tissues in the human body, skeletal 
muscle has a uniform structure that is preserved across each area of the body it occurs in 2. 
Skeletal muscle can be visualized as a series of cylinders wrapped inside another series of 
cylinders, continuing into the molecular level (Figure 1a). For example, the bicep of the arm, 
the muscle that causes adduction of the forearm, is constructed of multinucleate muscle cells, 
called muscle fibers, bundled together in a muscle fascicle. These muscle fibers are made up 
of myofibrils, which are strings of the structures that produces muscle contraction: the 
sarcomere (Figure 1). The sarcomere is where skeletal muscle myosin interacts with F-Actin 
filaments to shorten the muscle; many other proteins are involved to make this contraction 
work, but my thesis will only focus on actin and myosin. ATP is hydrolyzed so that the 




process is occurs across the myofibril, a contraction is produced. Relaxation of the 
sarcomeres happens when Actin is no longer actively moved by myosin. This muscle 
relaxation allows it to extend, such as when you put the weight down and relax your arm. 
 
1.1.2 Skeletal Muscle Function 
Skeletal muscle’s primary function in an organism is locomotory. Any voluntary 
movement requires the use of skeletal muscle. Maintaining an upward posture on two legs is 
Figure 1. Skeletal muscle structure, from Frontera and Ochala, 2014. The muscle consists of a 
muscle fiber (a), which contains the myofibril (b). Inside each myofibril contains the basic 
contractile unit of skeletal muscle: the sarcomere (c). The sarcomere contains the proteins actin 




only able to be achieved via our skeletal muscle. This is done through the contraction of the 
muscle fibers in unison in the specific muscle being used (see section 1.1). However, 
movement is not the only function of the skeletal muscle; it also has metabolic functions and 
is vital to thermoregulation.  
When an individual partakes in intense exercise, the body will start to heat up, eventually 
producing sweat in order to cool itself down. The heat produced from the hydrolysis of ATP 
travels to the bloodstream which raises overall body temperature, and triggers perspiration 1. 
This regulation of the body temperature provides an advantage especially when our bodies 
experience a drop in temperature, also known as cold stress. Since we do not have proper 
insulation to deal with a cold stress, one of the solutions we employ is through our skeletal 
muscles. Shivering is a primary example of this. When we experience cold stress, we shiver- 
a process wherein many skeletal muscle groups, begin to contract rapidly at about 20% of 
their force-generating capacity 3. This rapid contraction produces a large amount of heat 
which travels through the body and increases overall temperature, staving off the detrimental 
effects of cold stress.  
Recent studies have also pinned skeletal muscle as a possible endocrine organ. An 
endocrine organ produces and secretes regulatory hormones into the blood to be transported 
all over the body. This is partially seen in skeletal muscle through the secretions of molecules 
called myokines 4. These molecules are a type of cytokine, small secreted proteins that have a 
targeted effect on the interactions and communication between cells, and have autocrine, 
paracrine, and exocrine functions 5. The ability to improve in structure and function while 
also combatting the effects of aging and disease seen in skeletal muscle requires a lot of 




bone, and cardiovascular system (Figure 2) 4. Autocrine and paracrine function of myokines 
connect skeletal muscle to organs essential for the regulation of growth and lipid metabolism 
of the skeletal muscle, which provides a feedback loop used for adaptation of the muscle to 
exercise training 6. Myokines also have an endocrine function that can mediate the whole-
body effects of exercise further than that of the skeletal muscle, an example being the 
possible counteracting of the pro-inflammatory adipokines released by the adipose tissue 
during prolonged inactivity. The endocrine function of the skeletal muscle helps support the 




















Figure 2. Stress on the skeletal muscle can induce cell signaling through the 
use of myokines Taken from Ost et al., 2016. The myokines produced as a 
result of cellular stress are highlighted in red, exercise induced myokines are 
highlighted in blue, and myokines produced by both conditions are 





1.1.3 Attachment of the Muscle Fibers to the ECM 
To effect conscious movement, the skeletal muscle contracts, generating a force on the 
skeletal system. These local forces can be immense, especially at times of intense exercise, 
potentially strong enough to tear the muscle, detaching the fiber from its neighbors or from the 
tendon, the band of connective tissue that connects the muscle to bone. To combat this, the 
muscle fibers need to be anchored properly to the extracellular matrix (ECM). They are 
indirectly anchored to the ECM by transmembrane receptor complexes 7. These complexes are 
essential for the proper attachment of the muscle fibers to their ECM which prevents 
detachment during contraction. The two receptor complexes (Figure 3) in skeletal muscle fiber 
attachment are the integrin-mediated receptor complex and the dystrophin-glycoprotein-
mediated complex. Each of these complexes consist of a variety of proteins such as dystrophin, 
alpha- and beta-dystroglycan, laminin, etc., and are coded for and produced by different genes. 
For example, the dystrophin protein (see gray boxes in figure 3) is coded by the DMD gene, 
one of the largest genes in the human genome, consisting of about 79 exons and making up 
roughly 0.1% of the genome 8. Dystrophin attaches to the actin cytoskeleton, long stiff chains 
of actin protein that form part of the cytoskeleton and give the cell structure, with sarcoglycan 
proteins on the other end. The sarcoglycans consist of four transmembrane glycoproteins and 
respond to muscle contractions, transducing mechanical information into a cellular signal 9. 
The next protein structure in the attachment complex is dystroglycan, which consists of two 
subunits: alpha- and beta-dystroglycan (purple structures in figure 3). Dystroglycan is then 
attached to laminin, one of the most widely expressed ECM proteins (yellow, stick-like 
structure in figure 3) 10. It plays critical roles in embryonic development, especially the binding 




exists in many different isoforms in many places in the body 11. In the dystrophin-glycoprotein-
mediated attachment complex, all of these protein structures are connected to one another, and 
finally to collagen (gray proteins in Figure 3), where the fiber is secured. Without the 
dystrophin protein, the dystrophin-glycoprotein complex (DGC) is disrupted. 
These proteins form the complexes that span from the actin cytoskeleton, through the 
muscle cell membrane, to the ECM. This structure can be thought of like links in a chain. A 
weakening of one of these links can pose a threat to the breakage of the chain, releasing 
whatever object is held on at the other end, which is actin in the case of muscle. When one or 
more of the proteins do not work properly, or have been weakened, the muscle cell can 
detach and undergo cell death. When this happens at a large scale in the muscle, we see 
atrophy of the muscle itself. The muscle will then attempt to rebuild broken muscle fiber 
cells and will replace it with a greater amount of contractile tissue, a process called 
hypertrophy 12. 
 
Figure 3. Cell Adhesion Complexes are Made Through Many Different Proteins, 
Adapted from Goody et al., 2015. Skeletal muscle cell adhesion is done through a 
variety of proteins. All of these proteins are coded for in different genes and a 





1.1.4 Muscle Fiber Repair and Regeneration 
Muscle is one of the most dynamic tissues in the body 2. This is partially due to the 
normal protein turnover rate in muscle, aside from that due to damage or stress, which is 
about 5.7 g·kg−1·day−1 13. The rate of protein turnover increases greatly during exercise and 
the resulting rate depends on the type, length, and intensity of the exercise 14,15. The increased 
protein turnover is essential to the repair and regeneration process that occurs in the muscle 
fibers after exercise. When a person takes part in intense activity, such as weightlifting, the 
person will probably feel a soreness in the muscle groups worked 24-48 hours after the 
workout. This soreness is the muscle fibers that were torn and damaged during the workout 
being repaired. The muscle fibers will then be repaired, and the contractile tissue will have 
increased, improving muscle performance that will decrease damage due to the next intense 
exercise. This is called muscle hypertrophy 12. 
 Regeneration and repair in muscle is coordinated through many different mechanisms 
and processes which involve cell-cell and cell-matrix interactions 16. Muscle repair can be 
divided into three different phases: the demolition phase, the repair phase, and the 
remodeling phase 16,17. The demolition phase is characterized by the sealing of damaged 
myofiber ends, inflammation,  and the necrosis and clearing of damaged muscle fiber 
segments 17. The clearing of necrotic muscle fiber is done through the recruitment of cells 
such as macrophages and neutrophils 17,18. The next phase, the repair stage, occurs when 
satellite cells activate, proliferate, and differentiate to replace myofiber segments or to form 
new muscle fiber cells; formation of fibrous scar tissue occurs in this stage as well depending 
on the intensity of the damage 17. The final stage involves muscle fiber repair in order to 




which allow for a greater force to be exerted by the muscle during the next session of 
exercise 19.   
In people with healthy skeletal muscle, this process is repeated whenever the muscle is 
damaged, and proper function returns quickly. However, this process can be impaired by 
muscle diseases. When this happens, the overall health of the skeletal muscle tissue is 
decreased. This leads to a cascade of symptoms all over the body, and an eventual decrease 
in quality of life.  
 
1.2 Muscle Disease 
There are many diseases and disorders that negatively affect the skeletal muscle. They 
can stem from a variety of different origins such as neuronal, congenital, molecular, etc. One 
of the most common symptoms of muscle disease is atrophy: the decrease in size of the 
muscle fibers, eventually leading to the weakening of the muscle 20. Depending on the 
severity of the disease, atrophy of the muscle can impede on everyday activities and often 
worsens as the person ages, eventually leading to a decrease in the length and quality of life.  
1.2.1 Congenital Muscular Dystrophies 
Congenital muscular dystrophies (CMDs) are a group of muscle diseases that occur when 
there is a change in the genetic code of the individual in a location essential to skeletal 
muscle health and function. These mutations in the DNA cause a loss of function in the 
proteins that anchor the muscle fiber to the basement membrane. When there is improper 
anchoring, the muscle fiber can detach and undergo cell death.  
Symptoms of CMD is often initially observed in infants (although late onset is possible). 




in young patients, followed by a progressive weakness which may lead to the loss of the 
ability to walk or use of limbs. However, different CMDs affect different muscle groups at a 
differing severity level. Some CMDs may affect the cranio-facial or ocular muscles while 
others effect the muscles at the limbs and shoulders. The most common CMDs are Duchenne 
and Becker muscular dystrophies (DMD and BMD, respectively), which effect 
approximately 1 in every 5,500 to 7,700 men age 5 to 24 21. In the case of this study, DMD 
will be the primary focus. However, any mutations in the DNA that code for the proteins in 
the adhesion complexes can cause a different CMD. Examples of these are ITGA7 (integrin-
alpha 7), LAMA2 (laminin-alpha 2), and COL6-RD (collagen VI) genes.  
Mutations in ITGA7 cause a congenital myopathy due to a loss of function in the integrin 
proteins in the adhesion complex (figure 3). Mutations in the laminin-alpha 2 proteins coded 
for in the LAMA2 gene cause LAMA2 CMD also known as merosin-deficient congenital 
muscular dystrophy (MDC1A) and is characterized as early onset and very severe 22.  
1.2.3 Duchenne Muscular Dystrophy 
Duchenne Muscular Dystrophy (DMD) is a congenital muscular disease caused by a X-
linked mutation in the Dystrophin. This causes a loss of function in the dystrophin protein. It 
is usually diagnosed at an average of about 4 years of age, with symptoms often progressing 
quickly 23. Increased muscle weakness, loss of the ability to walk at a young age, respiratory 
and cardiac issues, and a lower quality of life are among the most common symptoms, with 
disease progression ultimately ending in a shortened life span.  
The dystrophin gene is a very large gene, spanning about 0.1% of the genome with more 
than 2,200 kb 8. Surprisingly, despite its size, the dystrophin gene only contains about 79 exons, 




mostly stem from deletions of one or more exons 23. This makes up about 65% of the cases, 
while duplications make up about 6%-10% of the case, and the rest consisting of small 
mutations (missense, nonsense, and splice site variations) 23. These mutations interrupt the 
open reading frame (ORF) and lead to the absence of dystrophin protein throughout the body. 
A shift in the ORF that does not cause a complete absence of the dystrophin protein, but a 
partially functioning, abnormal shaped protein, you get  Becker muscular dystrophy (BMD), a 
more mild form of DMD 25. Without the dystrophin protein, there is detrimental effects of the 
muscle across a large majority of the muscle. It even extends past the skeletal muscle, as 
patients often show an abnormal electrocardiogram by the age of 18, indicating symptoms 
within the cardiac muscle and respiratory system and leading to an early death in their late 
teens to early twenties 26. Disease progression in DMD and other muscle disease stress the 
importance of skeletal muscle health and how it is linked to overall health of the body and the 
need for further therapies and an eventual cure.  
1.2.4 DMD Patients Have Lower Activity Levels 
 Movement abnormalities and difficulties are common symptoms of DMD with a loss of 
movement independence and the need for a wheelchair occurring by around the age of 10 23. 
Activity levels are severely reduced by this time in severe DMD patients. Without proper 
dystrophin function, muscle fibers are be more susceptible to damage and the regenerative 
abilities of myofibrils is hindered 23. Strenuous exercise or activities that a healthy person would 
normally partake in such as a run or bike ride is highly advised against, as irreversible damage to 
the muscle fibers could ensue and exacerbate disease progression 27. Despite the potential 




provide a potential therapeutic effect, since exercise in a healthy person has many benefits on 
overall health and wellness. 
 
1.3 Exercise and Inactivity on Muscle Structure and Function  
 It is accepted widely that a normal exercise routine is imperative for the function of the 
human body. Numerous studies have shown that normal exercise reduces the risk for many 
different diseases such as coronary heart disease, hypertension, diabetes mellitus, and can 
extend the life expectancy of a person 28. Alternatively, insufficient activity and sedentary 
lifestyles have the opposite effects. Gain of abdominal and visceral fat and a higher risk of type 
2 diabetes and heart disease are among many other symptoms that may arise from the lack of 
regular exercise 29. Done under proper conditions, exercise is among one of the most important 
things that can be done to improve health and quality of life in a healthy individual.  
 
1.3.1 Exercise and Its Beneficial Effects on the Body 
 Regular exercise, especially dynamic exercise of moderate intensity, improves endothelial 
function, vascular tone regulation (through the increase of endothelial nitric oxide production) 
that staves off cardiac-related illness, and improves movement abilities 30. In younger people, 
exercise shows similar benefits such as a lower heart rate, left ventricular ejection fraction, 
maximal oxygen uptake, and lower risk of diseases such as type 2 diabetes and heart disease 
31. 
 When a person goes through intense exercise, they are putting strain on their muscle fibers 
and whether they know it or not, they are putting these fibers through a cycle of breakdown 




intense power-lifting workout, many muscle fibers break, the damaged tissue is then broken 
down, and contractile tissue is regenerated, often with additional tissue. The addition of new 
contractile tissue lets the muscle exert that same force with less damage to the muscle fibers. 
The consistent addition of contractile tissue due to intense exercise is called muscle 
hypertrophy. Athletes and power-lifters utilize hypertrophy to build muscle strength and 
improve performance.  
  
1.3.2 Inactivity and Its Detrimental Effects on the Body 
 Regular activity clearly shows various benefits to the overall health of the body. 
Conversely, prolonged inactivity has been shown to have a variety of negative effects on the 
health and function of the body. Not meeting the minimum recommended amount of activity, 
which is about 30 minutes of moderate-intense physical activity 5 days a week, is a problem 
seen across all life stages from childhood past adulthood 29. Prolonged inactivity not only 
decreases muscle mass and strength, but it is shown to be positively associated with all-cause 
mortality, fatal and non-fatal cardiovascular disease, type 2 diabetes, and metabolic syndrome 
32.  
Inactivity has a profound effect on the skeletal muscle of an individual. Increased 
fatiguability upon resumption of activity, loss of muscle mass, and mitochondrial dysfunction 
are all linked to prolonged inactivity 33–35. When a person becomes inactive, over time there 
is a reduction in protein synthesis and an increase in proteolysis due to the decreased use of 
transcriptional activity 35. The person is no longer using their muscle fibers beyond that of 
basic movement, which basically tells the body there is no use for excess proteins or 




and their transcripts, ultimately diminishing the amount of muscle fibers. This is a process 
called muscle atrophy. With muscle atrophy, there is also a weakness of the muscles and a 
decreased amount of force those muscles are able to generate. About 1 week of inactivity, 
such as bed rest decreases as much muscle as would be gained from 12 weeks of intense 
resistant-type exercise training 36.  
Muscle disease patients, including DMD patients, experience high levels of muscle 
atrophy, reducing functionality of those muscles, and lowering activity levels. Gradual 
resumption of activity in a healthy individual can rebuild muscle groups, reduce adipose 
tissue deposits, and reduce the risk for illness. However, in an individual with an illness such 
as muscle disease, the process of activity versus inactivity becomes more complicated.  
 
1.3.4 Exercise and Activity and Its Effect on Muscle Disease 
The main hallmark of muscle disease is increased muscle atrophy. The breakdown of 
muscle fibers and weakening of the muscle groups is due largely to the damage sustained to 
the fibers from improper anchoring to the ECM. With a lack of proper anchoring, the rate of 
breakdown exceeds that of the rate of regeneration, and damage to the muscle ensues. As 
there is no current cure for muscle disease, there is a large stress put on therapies in order to 
extend quality and length of life. Physical therapy is typically the most used therapy to help 
combat DMD and may include some type of exercise. While a current set of international 
care guidelines exists and recommends individuals engage in regular submaximal activities, 
large-scale randomized control trials are lacking, and data between smaller studies is variable 
27,37–40. For example, a study done by Voet et al. published in 2019 had participants with 




or a combination of both in order to assess the benefits or harm to muscle strength and 
aerobic capacity 41. The researchers showed uncertainty in their results and failed to show 
concrete evidence of improvement to muscle strength or aerobic capacity 41. Due to 
limitations in human studies and variability in data, researchers have turned to animal models 
in order to explore and understand mechanisms behind DMD and other muscle diseases.  
1.3.5 Animal Models of DMD and Exercise 
Currently, there are about 60 different animal models of DMD ranging from mammalian 
such as canine, feline, and mouse models, to non-mammalian models including C. elegans, 
fruit fly, and zebrafish models 42. The most widely used animal model of DMD is the mdx 
mouse, Mus musculus, discovered in the 1980s 42. The mutation in the mdx mouse is a 
nonsense point mutation, C-T transition in exon 23 that aborts the full-length dystrophin 
expression 42,43. Studies with exercise and mdx mouse have shown inconsistent results, but 
recent studies show more promising results. For example, a study done by Zelikovich et al. 
published in 2019 tested the effects of moderate and low intensity exercise on tetanic and 
specific force, respiratory capacity, and cardiac function 44. They found that exercised mice 
mdx mice improved tetanic and specific force, increased respiratory capacity, and enhanced 
cardiac function as compared to the sedentary group. The researchers also found a dose-
dependent increased in serum adiponectin, a protein hormone responsible to the influence of 
the body’s response to insulin.  
While many exercise studies of DMD have been performed, studies on inactivity and its 
effects on disease mechanisms and progression are lacking. It is well established that 
individuals suffering from DMD exhibit lower activity level compared to healthy individuals 




exercise preserves muscle fibers integrity and prevents myonecrosis 46,47. Another study done 
by Li and Arner in 2015 chemically induced inactivity with BTS in dmd mutant zebrafish 
from 18 hours post fertilization (hpf) to 4 dpf  which resulted in better organization of muscle 
fibers seen from birefringence compared to the active controls, further suggesting that 
inactivity helps preserve muscle fibers 48. 
Conversely, a study done by Hourdé, C. et al in 2013 found that inactivity in mdx mice 
may lead to an increase in susceptibility to contraction-induced injury and that voluntary 
activity may help protect from this susceptibility 49. Another study done on mdx mice by 
Lindsay et al. in 2021 that had a stress-induced short period of inactivity showed that 
inactivity was not associated with acute skeletal muscle contractile dysfunction, but high 
passive stiffness could be possibly attributed to a small, but significant increase in muscle 
fibrosis 50. Since these findings are varied, more research is needed in order to fully 
understand the effects inactivity is having on DMD. 
While mdx mice are a widely used model and allow us to research deeper into the 
mechanisms behind DMD without the limitations of human models, there are limitations to 
mice models as well. Young mdx mice show little weakness and live up to 80% as long as 
their healthy control counterparts, far longer than human DMD patients 42. It has been 
hypothesized that this may be attributed to an upregulation of utrophin seen in mdx mice not 
seen in humans. Efforts to “humanize” the mdx model show variable results, and more 
research is needed in order to establish a more “human model” of mouse DMD 51. However, 
other animal models are being increasingly used to study DMD, even in exercise studies. One 
example is zebrafish (Danio rerio). A study done by Kilroy et al. published in 2020 




of exercise, on a zebrafish model of DMD 45. They found that NMES returns gene expression 
to wild-type levels, increases muscle adhesion to the ECM, and remodels the ECM to support 
more regeneration, while inactivity had a deleterious effect on disease progression. These 
results provide further evidence that exercise is beneficial for DMD patients and inactivity 
may have a negative effect on disease progression. The use of zebrafish has been 
increasingly used for a variety of studies and provides an attractive model to study DMD.  
 
1.4 Zebrafish as a Model of Study 
 Zebrafish (Danio Rerio) have been widely accepted as a useful model for developmental 
biology and genetics experiments. Zebrafish development is rapid, as embryos fully develop 
their major organ systems, including cardiovascular, nervous, digestive, and muscle systems, 
in less than a week 52. While they develop, the skin is transparent which makes observation 
and imaging of organ system development especially easy and efficient. There is also high 
fecundity in zebrafish; females are able to produce many offspring, potentially up to 350 
offspring in a week 53. To reproduce, zebrafish fertilization is external, which lets the 
embryos be collected shortly after fertilization occurs, providing researchers access to all 
stages of development. The high fecundity and rapid development allow for multiple 
experimental trials be conducted over a relatively short amount of time.  
 The cost of maintenance of zebrafish is relatively low as well. The embryos do not need 
food until 5 days post fertilization, which is the conclusion of many developmental 
experiments as their organs have already developed. Different transgenic or mutant lines are 




the adult zebrafish also allows for multiple fish to be kept in the same tank, reducing the need 
for multiple tanks at large sizes, keeping maintenance costs low.  
 Zebrafish are also used as a model of study due to the molecular tools available and their 
genetic amenability. Examination of specific gene function through the development of 
transgenic lines, large scale mutagenesis screens, or antisense gene knockdown is highly 
achievable with zebrafish 52. It has been shown by the UK Sanger institute that almost 70% 
of human genes have functional homologs in zebrafish, including many of the genes that 
code for the proteins that attach the muscle fiber to the basement membrane 54. Genetic and 
functional conservation is important because that means that zebrafish display similar 
phenotypes resulting from the same mutations in their genome as humans. In other words, a 
mutation in a gene that encodes for a protein involved in muscle attachment in a zebrafish 
will produce similar muscle attachment deficiencies as mutations in the homologous human 
genes.  
 Two common methods of investigating gene function in the zebrafish model are 
morpholino-mediated protein knock down and CRISPR/cas9 mutagenesis. Morpholino (MO) 
antisense oligomers are synthetic oligonucleotides that interfere with mRNA translation or 
processing, which results in protein knock down or a “pseudo” mutant scenario. Advantages 
to MOs are that large numbers of “pseudo” mutants can be generated for experiments and 
maternal and embryonic proteins are both knocked down. Disadvantages include only 
temporary protein knock down, injection variability, off-target effects, and results that often 
don’t line up with mutant findings 55. Alternatively, we can now relatively easily alter DNA 
sequences through CRISPR/cas9 mutagenesis. This system allows genome editing of 




sequence and replace it with a customized DNA sequence 54. Research labs and institutes are 
using this technique to create mutant lines of zebrafish to model different genetic diseases.  
1.4.1 Zebrafish Muscle Development 
 Zebrafish muscle development makes them an ideal model to study muscle disease. The 
development and physiology of skeletal muscle in zebrafish shares many commonalities with 
higher vertebrates, including mammals such as mouse and dog models 56. However, there are 
differences in the skeletal muscle of zebrafish compared to higher vertebrates that can be 
viewed as experimental advantages. In zebrafish, the different muscle fiber types, fast-twitch 
vs slow-twitch, are spatially segregated. This allows for the observation of fiber-type specific 
effects when experimenting while also providing an opportunity for identifying the 
mechanisms that regulate fiber-type specification 56. Development of the muscle is also 
easily observed. Skeletal muscle development in zebrafish is rapid and completed in a few 
days. The muscle originates from somitic cells as the precursors to the individual fibers. 
These precursor cells elongate and eventually become the actual muscle fibers, which are 
then separated into segments called myotomes (figure 5) 57. These myotomes are 
characterized by having a sideways “V” shape, also known as a chevron, with an angle of 
approximately 90º. The myotendinous junction (MTJ) separates the myotomes and is the area 
in which attachment to the ECM occurs. Proper MTJ anchoring is essential for fiber health 
and overall muscle health.  
 
1.4.2 Zebrafish Model of DMD 
 For this project, we used dmd zebrafish to model human DMD 58. dmd mutant zebrafish 




orthologue of the human Dystrophin gene and result in dystrophic pathology by interrupting 
the link between the actin cytoskeleton and the ECM in skeletal muscle cells 58,59. The 
disease progression of dmd mutant zebrafish mimics that of a human patient very similarly as 
opposed to the mdx mouse model. Similarity to the human disease, combined with the 
advantages of a zebrafish model outlined in section 4 allow for a useful and potentially more 
relevant model of DMD. Birefringence imaging (Figure 6E) allows for easy visualization and 
quantification of disease progression, while tools such as DanioVision and 
immunohistochemistry (IHC) allow for further analysis into muscle function and structure, 
respectively. Overall, dmd mutant zebrafish provide an excellent model of DMD and are the 
model used to conduct this project.  
 
1.5 Project Overview 
 The sole study examining the effects of inactivity on dmd mutant zebrafish showed a 
deleterious effect on muscle structure and function 45. This project aims to expand the 
research done on inactivity in DMD mutant zebrafish, to further understand the underlying 
mechanisms of disease progression and effects on muscle structure and function. We 
Figure 4. The Development of Skeletal Muscle from Somites: Adapted from Goody, Carter, Kilroy, 
Maves, & Henry, 2017. The development of skeletal muscle starts with the somite (pictured on 
the right) which contains short-precursor cells. These cells elongate, attach to ECM, and then 





hypothesize that extended inactivity will have a negative effect on the structure and function 
of the muscle along with a lower probability of survival in dmd mutant zebrafish. 
 Inactivity was induced through a N-benzyl-p-toluene sulphonamide (BTS) solution, an 
inhibitor of the Ca2+-stimulated S1 ATPase that blocks gliding motility 60. BTS has been 
shown to prevent any force transduction or movement in zebrafish, with little effect on the 
M- and Z-lines of the muscle fibers 61. Zebrafish mutants and wild-type (WT) controls were 
either treated with 50 µM BTS solution, inducing inactivity, or put in a DMSO control 
treatment at the same concentration. Birefringence imaging was done to quantify disease 
severity and progression through calculation of mean grey value (MGV), DanioVision was 
used to analyze muscle function through measurements of distance (in mm) and velocity (in 
mm/s). The results of this study help to further understand the mechanisms behind inactivity 
and DMD in hopes to apply the data into a broader context to properly address treatments 










CHAPTER 2:  
MATERIALS AND METHODS 
2.1 Materials 
2.1.1 1x ERM 
 To prepare a 20X stock solution the following was added to 800 mL of ddH2O: 17.5 g 
NaCl, 0.75 g KCl, 2.9 g CaCl-2H2O, 0.41 g KH2PO4, 0.142 g Na2HPO4 anhydrous, and 4.9 g 
MgSO4-7H2O. Once in solution, ddH2O was used to fill up to 1 L. This solution was then filter 
sterilized into an autoclaved 1-L flask and stored at +4 ºC. 1X ERM was prepared by adding 50 
mL of the 20X stock solution, 0.3 g of NaHCO3, and one to two drops of methylene blue to 950 
mL of autoclaved ddH2O. 1X ERM was stored at room temperature. 
2.1.2 Tricaine  
 Tricaine was used to briefly halt movement in order to properly image birefringence. A 
stock solution of tricaine (MS-222, Sigma-Aldrich) was prepared by adding 400 mg of powered 
tricaine and 800 mg of Na2HP04 (Anhydrous) to 100 mL ddH20. The pH was adjusted to 7.0 if 
necessary, with 1M HCl or 1M NaOH. The stock solution was aliquoted and stored at -20 ºC. 
Working solutions were prepared daily for live imaging by adding 400 μL of the stock solution 
to 10 mL of 1X ERM (612 μM)  
2.1.3 BTS  
 N-benzyl-p-toluene sulphonamide (BTS) was purchased from Sigma-Aldrich in a 5 mg 
powder. The BTS powder was dissolved in 382.64 µL DMSO to make the stock solution and 
was kept at -20 ºC. To achieve a 50 µM as outlined in Codina et al., 3µL of the BTS stock 





2.2.1 Zebrafish Care and Maintenance 
 Adult zebrafish were kept on a 28.5ºC 14-h light/10-h dark cycle and embryos were 
collected from natural spawning of these zebrafish. We used sapjeta222a zebrafish for all 
experiments 58. Embryos were staged based on Kimmel et al., 1995 62. Experiments were 
conducted with the approval of the University of Maine Institutional Animal Care and Use 
Committee (IACUC). Embryo Rearing Media (ERM) was made in a 1 L bottle with 0.3 g 
NaHCO3, 50 mL 20x ERM stock, and brought to 1 L with ddH2O. Two drops of methylene blue 
were added after the ddH2O. Embryos were housed individually at 2dpf in 4x3 12 well-plate 
dishes with 3 mL embryo rearing medium (ERM) during experiments. Once at 5 (dpf), zebrafish 
were fed once daily. At 9 dpf, ERM was switched out with system water that the adult zebrafish 
are housed in.  
2.2.3 Birefringence Analysis 
 Birefringence is a unique and physical property in which light is rotated as it is passes 
through highly organized matter, such as the pseudo-crystalline array of muscle sarcomeres 63. 
With zebrafish larvae being optically transparent, birefringence is a rudimentary and efficient 
way to quantify dystrophic muscle and ultimately, disease progression, as damaged muscle does 
not reflect light. Zebrafish were placed in 612 μM of tricaine in 1X ERM immediately 
prior to imaging and then transferred to a 35-mm glass bottom dish. Birefringence images were 
taken on a Leica MZ10 F Stereomicroscope with a Zeiss AxioCam MRm or Leica DMC5400189 
camera attached. An analyzer in a rotatable mount (Leica) was attached to the objective and the 




 Zebrafish displaying well organized myotomes with bright white or light grey muscle 
were classified as wild-type (WT) siblings while those that had patchy dark grey or black areas, 
indicating dystrophic or disorganized muscle fibers, were classified as dmd mutants. Imaging 
parameters and time was consistent across experiments.  
 Images were blinded before analysis and mean grey values (MGV) were calculated using 
FIJI software 64. The body of the zebrafish was outlined from the 7th to the 23rd myotome using 
the “polygon selections” tool and then MGV was measured. This was done three times to obtain 
three separate measurements, and then the average was used for calculations. All birefringence 
data were normalized to the average WT birefringence in each imaging session. MGVs were 
then presented as a percentage of the average MGV. The equation is below: 
 
𝐸𝑚𝑏𝑟𝑦𝑜′𝑠 𝑀𝐺𝑉
𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝑀𝐺𝑉 𝑜𝑓 𝑠𝑖𝑏𝑙𝑖𝑛𝑔 𝑐𝑜𝑛𝑡𝑟𝑜𝑙
𝑥 100 
 
 Birefringence was used to assess the change in muscle structure and quantify disease 
progression from 2 dpf to 8 dpf. A positive change in birefringence corresponds to an 
improvement in muscle structure. Conversely, a negative change in muscle structure meant there 
was a worsening of muscle structure.  
2.2.3 DanioVision Analysis 
 The DanioVision system and EthoVision XT 13.0 software (Noldus Information, Inc) 
was used to conduct high-throughput locomotion tracking studies to observe and quantify muscle 
function during inactivity at 5 dpf and 8 dpf. DanioVision uses a high-speed, infrared-sensitive 
camera to track movement of zebrafish. During the experiments, zebrafish were kept in their 12-




at 28 ºC and a temperature control unit was used to ensure the temperature stayed constant. 
Zebrafish were allowed to acclimate to the temperature for 5 minutes. Using the EthoVision 
software, the zebrafish went into a period of dark followed by two light-on/off cycles, where the 
white light was turned on at 100% intensity for 5 minutes and then turned off for 5 minutes 45. 
Total recording time was 25 minutes.  
 Once recording was finished, the data was exported into an Excel file. Raw data includes 
distance swam in mm and mean velocity across 0.033-second periods. Distance and velocity 
were analyzed in GraphPad Prism 9.  
2.2.4 BTS Inactivity Experiment  
 Zebrafish embryos were collected and grown until 2 dpf, the day of disease onset. At 2 
dpf, birefringence images were taken as described in section 2.2.3. The embryos were then put 
into individual well dishes in a 12-well plate, separated by treatment group. There were 4 
treatment groups: WT Inactive, WT, dmd Mutant Inactive, and dmd mutant. The BTS-induce 
inactive groups received 3 µL BTS stock solution in 3 mL ERM. The CT groups were treated 
with 3 µL DMSO. From 2 dpf to 5 dpf, the ERM solutions were changed daily at approximately 
the same time. At 5 dpf, the zebrafish were removed from the treatment groups and birefringence 
images were taken. The zebrafish then were placed into 3 mL ERM with no treatment solution. 
DanioVision was done 4 hours later to allow proper time for activity to resume. ERM was 
changed daily at approximately the same time until 8 dpf. At 8 dpf, birefringence images were 
taken and DanioVision was done 4 hours later. The embryos were then tracked for survival and 





2.2.5 Statistical Analysis 
 All statistical analysis was done in GraphPad Prism 9. Normality of the data was first 
tested using the Shapiro-Wilk test. If the data set passed the normality test, an unpaired two-
tailed t test was performed between two data sets (i.e., dmd inactive mutants versus dmd mutant 
controls). An ordinary one-way ANOVA followed by a Turkey’s multiple comparison test was 
performed between the four treatment groups’ data sets. If the data set failed to pass the 
normality test, a Mann-Whitney U test was performed to compare two data sets while a Kruskal-
Wallis test was performed to compare the four treatment groups’ data sets. Significance for all 




3.1 Transient BTS Treatment Does Not Alter Muscle Structure in dmd Mutant Zebrafish 
 We sought to analyze the change in muscle structure in dmd mutants as compared to the 
control treatment groups through calculation of percent MGV in order to quantify the dystrophic 
muscle. We found that at 2 dpf, 5 dpf, and 8 dpf, there was no significant difference between the 
dmd mutant inactive and dmd mutant groups (Figure 6A, B, C,). Also, there was no significant 
different between the WT and WT inactive groups at 2 dpf and 8 dpf (Figure 6A, and C).  
 Over the three time periods, we saw a decrease in MGV from 2 dpf to 5 dpf in the WT 
Inactive, dmd mutant inactive, and dmd mutant groups, followed by an increase in MGV in the 
WT Inactive group only (Figure D). The dmd mutant and dmd mutant inactive groups followed a 
similar trend throughout all time groups (Figure D). WT MGV did not change over the time 




followed the same disease progression as the active dmd mutant zebrafish over time, suggesting 
that inactivity is neither hindering nor improving muscle structure in this mutant. Also, these data 
shows us that inactivity has a detrimental effect on WT muscle that can be recovered shortly 







































Figure 5. Inactivity does not have a negative effect on muscle structure. (A.) Percent MGV at 
2 dpf shows no significant different difference in percent MGV between the dmd Mutant and 
dmd Mutant Inactive groups as well as the WT and WT Inactive groups. (B., C.) Percent 
MGV at 5 dpf as well as 8 dpf shows no significant difference between the dmd Mutant and 
























































































































































































3.2 Muscle Function in dmd Mutant Zebrafish is not Affected By BTS-Induced Inactivity. 
 We next sought to understand the effects of inactivity on muscle structure in the dmd 
inactive mutants as compared to the CT treatment groups. We used DanioVision to measure 
distance (in mm) and velocity (in mm/s) in order to quantify swimming ability and attribute that 
to muscle function. We saw no significant difference in distance or velocity between the dmd 
mutant inactive and dmd mutant groups as well as the WT inactive and dmd mutant groups at 5 
dpf (Figure 7A, B). At 8 dpf, the only significant difference in distance was between the WT 
inactive and the dmd mutant inactive groups (Figure 7C), while with velocity, the only 
significant difference was between the dmd mutant groups and the WT groups (Figure 7D). 
These findings show that muscle function analyzed through distance and velocity was not 
different between the dmd mutant and dmd inactive mutants at either 5 dpf or 8 dpf, suggesting 














































Figure 6. Inactivity does not have a negative effect on muscle 
function via distance and velocity. DMSO sapjes were not 
significantly different in distance or velocity from BTS sapjes at 5 
dpf (A and B). At 8 dpf, the only groups that were significantly 
different was the BTS sapjes and the WT BTS group for distance (C) 





CHAPTER 4:  
DISCUSSION 
 After analysis of the percent MGV throughout the time periods, we did not see a 
significant difference between the dmd mutant group and the dmd mutant inactive group (Figure 
6A-C). This shows that while inactivity is not making dmd inactive mutants worse than the 
control mutants, it is not helping the dmd inactive mutants improve in muscle structure. Often 
times, a patient suffering from DMD becomes inactive or is told to reduce activity to simply 
going about their daily life, in order to preserve the muscle fibers. Our data did not provide any 
evidence that inactivity preserves muscle fibers and disease progression follows a similar pattern 
to the control mutant group. Conversely, previous data by Kilroy et al. show a worsening effect 
on muscle structure after the same period of inactivity when compared to the control mutant 
group 45. The difference in our data could be attributed to the chemical used to induce inactivity. 
Kilroy et al. used tricaine (MS-222) for their inactivity studies. Tricaine works by blocking the 
voltage-sensitive sodium channels, preventing a voltage-dependent increase in sodium 
conductance, and ultimately blocking muscle contraction 65. Adverse effects are seen mostly in 
the CNS and cardiovascular system; however, it is not yet fully understood. A common response 
to zebrafish treatment with tricaine is elevation of heart rate and respiration, followed by a 
depression of cardiovascular and respiratory function, resulting in hypoxia, a lowered 
concentration of blood O2  
65. While not a direct effect on the musculature, lowered blood 
concentration and changes in heart rate could have residual effects on already damaged muscle 
due to dmd that are not seen in BTS treatment in zebrafish.  
 Another study similar to what was done in this thesis is by Li and Arner et al. in 2015. 




and was done through 4 dpf. They found that the BTS treated dmd mutants displayed higher 
birefringence when compared to the DMSO control dmd mutants and was confirmed through 
quantification of birefringence intensity 48. These data contradict what was found in this thesis, 
as we did not see an improvement in the muscle structure when compared to dmd mutant 
controls. One of the reasons for this could possibly be attributed to time of treatment. Whereas 
our dmd mutants entered BTS-induced inactivity at 2 dpf, the BTS-induced inactivity treatment 
in Li and Arner’s experiments began at 18 hpf. At this time, zebrafish are not free swimming, as 
muscle development and organization is still occurring 57. At 2 dpf, the muscle has been 
developed and the larvae are free swimming, opening up an increased opportunity for 
contractile-induced damage, especially in dmd mutant zebrafish, that would otherwise not occur 
with inactivity beginning at 18 hpf. This would preserve muscle fiber integrity starting at 18 hpf 
and since the researchers did not look at muscle birefringence after resumption of activity past 
one day post BTS washout, it is likely that there would be no evidence of dystrophic muscle 
within the time of treatment. It is important to wait until disease onset to initiate the treatment 
groups because DMD patients often first get diagnosed after there is already damage due to 
normal activity levels (typically in children). The dmd mutant zebrafish in the research presented 
in this thesis started out with dystrophic muscle due to their swimming levels being higher prior 
to BTS treatment and data was also collected 3 days post-BTS washout, which could account for 
the difference in results.  
 We also saw that WT inactive muscle structure was significantly decreased from 2 dpf to 
5 dpf. This negative effect of inactivity was what we expected to happen, however, it was not a 
lingering effect, as structure improved to WT levels after 3 days of activity resumption. This 




structure. Unfortunately, we did not see this negative effect with the dmd mutant inactive group 
when compared to the dmd mutant. This could possibly be attributed to the fact that the dmd 
mutant inactive embryos were already suffering from their muscle weakness initiated by dmd. 
Since the WT inactive embryos were at similar levels to dmd mutants after their treatment, dmd 
mutants possibly already were suffering from the impacts of dmd that manifested worse than the 
effects of inactivity.  
 In BTS treatments, there have been reports of disruption of the thick and thin filament 
organization in zebrafish, as BTS works through inhibiting myosin function through the 
blockage of ATPase activity and interaction with α-actin 61. This disruption in the interaction 
with α-actin causes disruption with the organization of the thick and thin filaments, with little 
effect on the M- and Z-lines 61. This disorganization may account for lower percent MGV 
measurements in BTS treatment groups, as birefringence imaging relies on highly organized 
structures, such as the sarcomere, to reflect light and glow under the polarized lenses. While this 
is something to consider, we saw that the dmd mutant inactive group had similar percent MGV 
measurements as the dmd mutant group and were not significantly different at any of the three 
time periods. Therefore, it is unlikely there was a significant effect on the disorganization of the 
thick and thin filaments that could be seen with birefringence. While it would be difficult to 
observe the organization of the thick and thin filaments at the current time, 
immunohistochemistry staining with phalloidin would fluorescently label the actin and would be 
a first step in seeing how BTS may be affecting the thick and thin filament organization. 
 There was also no significant difference in the muscle function, via swimming distance 
and velocity, between the dmd inactive mutants and the dmd mutants at 5dpf. This shows that 




mutants who were not inactive. The lack of a significant difference could be attributed to the 
differences in mild versus severe phenotype of the disease. DMD can have a varying severity and 
the embryos were not separated based on mild versus severe phenotypes. It is possible that one 
group may have had more severe mutants than another, and vice versa. This may have shown an 
evening-out effect of the distance and velocity between the BTS mutant group and the DMSO 
mutant group. Percent MGV calculations can be used to separate groups and observe differences 
in mild versus severe phenotypes. This can be done to see if the difference in phenotype could be 
affecting the swimming distance and velocity.  
 Also, the lack of significant difference between the WT inactive group and the dmd 
mutant group at 5 dpf in both distance and velocity could be attributed to the decrease in muscle 
mass resulting from inactivity. In a healthy individual, a period of inactivity reduces muscle mass 
and strength. Since the muscle is no longer being used, the proteins are broken down and the 
amount of contractile tissue is reduced. This can be seen in the WT inactive group. Since they 
are inactive, the muscle function is reduced to the levels similar to diseased, dystrophic muscle. 
Resumption of activity increases muscle function back to WT levels. This data helps to support 
our model of inactivity. 
 At 8 dpf, there is no significant difference between any group other than the BTS sapje 
and WT inactive groups with distance and WT and dmd mutant groups with velocity (Figure 
7C). This could be due to improvement in swimming abilities in the inactive groups. There may 
be an increase in distance and velocity from 5 to 8 dpf in the inactive groups that could account 
for the lack of significant difference between the groups, since there was 3 days allowed to 
recover and train the body to move about. However, it is difficult to accurately compare the 




conducted because of having to quickly quarantine due to a COVID-19 scare along with another 
replicate’s data at 8 dpf not being saved properly on the DanioVision computer. All other 
experiments were conducted without problems. Further study into the change in distance and 
velocity may help shed light on the lack of significant differences between the groups. 
Regardless, there is still no significant difference between the dmd mutant group and the dmd 
mutant inactive group, showing that inactivity was not making muscle function worse than the 
mutant controls.  
 This study can be improved in multiple ways. One of the ways that would improve the 
study the most would be separation of mild versus severe phenotypes. Mild versus severe can be 
calculated from percent MGV and embryos can be divided more evenly amongst the groups. 
This would potentially reduce the variation in muscle function and structure, along with survival 
that could possibly have skewed our results and provide a clearer picture of what may be 
happening as a result of inactivity. Also, human DMD shows variability in the severity as well, 
so separation of the mild and severe zebrafish would allow for a better parallel to the human 
disease.  
 In combination with separation of mild versus severe, another way of improving the 
study would be to collect MGV data over each day, as opposed to the three time points. This 
would allow us to see the change in muscle structure over time more clearly. Kilroy et al. 2020 
saw a difference in the change over time in percent MGV between mild and severe at 5 dpf to 8 
dpf 45. She saw that the mild inactive dmd mutants, while having higher percent MGV, 
experienced a more dramatic decline in their percent MGV after entering the recovery period at 5 
dpf. The severe inactive dmd mutants, having lower percent MGV, had a less dramatic decrease, 




definitely improve this study to see if there was the same pattern in the inactive dmd mutants in 
this project as well. Also, using DanioVision of the DMSO groups each day starting at 2 dpf and 
DanioVision of the BTS groups each day starting at 5 dpf (since there would be no movement in 
the BTS treatment from 2 dpf to 5 dpf) to analyze changes in muscle function over time could 
show how muscle function changes day by day. Collecting data over more timepoints overall 
would provide more information on how the disease progression is changing over time. 
 Immunohistochemistry staining of the muscle actin as well as the neuromuscular 
junctions (NMJ) would allow for a more in-depth look at the muscle physiology. Since Kilroy et 
al. induced inactivity through the neurons, it would be helpful to observe any differences in the 
NMJs between tricaine-treated and BTS-treated zebrafish. This could potentially explain 
differences in the data from the two studies. Furthermore, staining actin and myosin molecules 
would allow us to see if there was any disorganization of the thick and thin filaments as was 
previously shown to be attributed to BTS treatments. This would negate any potential decrease in 
percent MGV due to disorganization of these filaments and not the muscle disease phenotype 
itself.  
 From the data we collected, we can conclude that BTS-induced inactivity does not have a 
negative effect on the disease progression in DMD mutant zebrafish. Muscle function and 
structure, along with survival, was not significantly different in the BTS mutant zebrafish as 
compared to the DMSO mutant zebrafish. The inactive mutants seemed to follow a similar 
disease progression as the control mutants. In a broader context, this provides evidence that 
inactivity to preserve muscle fiber integrity in DMD patients may not be helping stave off the 




so that proper treatments and therapies can be applied to those diagnosed with any form of 
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